| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |